A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Clinical trial NCT01767857 · TERMINATED
Trial details
- NCT number
- NCT01767857
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-31
- Primary completion
- 2017-06-30
- Enrollment
- 643
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.